MARIAN MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $395K
- Transactions
- 228
- Companies
- 26
- Average per transaction
- $1,734
Who reported the payments
| CSL Behring | $93,120 |
| Corcept Therapeutics | $53,231 |
| AbbVie | $46,024 |
| Davol Inc. | $33,686 |
| Stryker | $26,015 |
| Medical Device Business Services, Inc. | $24,000 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | $19,405 |
| Recordati_rare_diseases_inc. | $16,339 |
| Si-bone, Inc. | $16,166 |
| UCB SA | $11,976 |
| Regeneron | $10,500 |
| Takeda Pharmaceuticals U.S.A., Inc. | $9,840 |
| Johnson & Johnson | $6,000 |
| Actelion Pharmaceuticals US, Inc. | $5,500 |
| Biosense Webster, Inc. | $5,125 |
| Bard Peripheral Vascular, Inc. | $3,628 |
| Boston Scientific | $3,000 |
| Abbott | $3,000 |
| Providence Medical Technology, Inc. | $2,640 |
| Pharmacyclics LLC, An Abbvie Company | $2,500 |
| Cochlear Americas | $1,700 |
| Fisher Scientific Company L.L.C. | $648 |
| Welch Allyn | $485 |
| Angiodynamics, Inc. | $421 |
| Zimmer Biomet | $339 |
| Hill-rom Company, Inc | $117 |